Discover top medications for 'treating Polyarteritis Nodosa'? This page compiles essential information on generic and brand-name drugs specifically used for Polyarteritis Nodosa treatment.Here, you ...

Background A 50-year-old man with a history of hyperlipidemia and hypertension presented to an emergency department after 10 days of fevers (temperature 40 °C), headache, malaise, myalgia, poor ...

Mutations in the CERC1 gene associated with deficiency of ADA2 protein have been implicated in the pathogenesis of cPAN and early-onset vasculopathy. Cutaneous polyarteritis nodosa (cPAN) is a benign ...

With the initial presentation of nodules, a clinician must rule out infectious disorders including various bacterial, viral, and parasitic infections. Other vasoocclusive disorders such as multiple ...

Some people respond promptly to therapy and can taper off treatment over many months. Others require long-term treatment. The outlook for patients with polyarteritis nodosa depends on the degree of ...

There is no consensus on the optimal treatment of polyarteritis nodosa associated with hepatitis B virus (HBV) infection. The potential risk of accelerating viral replication complicates the use of ...

We describe a patient who had polyarteritis nodosa associated with parvovirus B19 infection that regressed completely with intravenous immune globulin therapy. A 33-year-old woman was seen because of ...

Polyarteritis nodosa vasculopathy may be caused by recessive loss-of-function mutations in a single gene (CECR1) encoding adenosine deaminase 2 (ADA2), a finding with potential clinical implications, ...

Background. A 36-year-old, previously healthy man presented to an accident and emergency department with right-sided abdominal pain 7 days after he sustained a trauma to his right flank. He was using ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — A panel at ACR/ARP 2019 offered an overview of the new guidelines for giant cell arteritis, Takayasu’s ...